Kailera Therapeutics, Inc. (KLRA)

Kailera Therapeutics, Inc. (KLRA) is a healthcare company (biotechnology) based in the United States. The share price is $12.20, down 2.94% on the day, which values the company at $1.58B. Price as of 17 Nov 2026, 18:23 UTC, from Yahoo Finance.

Key facts

Share price
$12.20−2.94% today
Market value
$1.58B
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Kailera Therapeutics, Inc. in more detail

KLRA trades at -3.1× next year's expected earnings.

In its favour: More cash than debt.

1 of the superinvestors tracked here hold KLRA, including Andrew Spokes (0.1% of the portfolio).

Superinvestors holding KLRA

1 of the investors tracked here report a position in their latest 13F filing.

Kailera Therapeutics, Inc. (KLRA): questions and answers

What is Kailera Therapeutics, Inc.'s market cap?

Kailera Therapeutics, Inc. is valued at $1.58B at a share price of $12.20.

Does KLRA pay a dividend?

Kailera Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own KLRA?

In their latest quarterly filings, Andrew Spokes (0.1% of the portfolio) hold KLRA. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Kailera Therapeutics, Inc. (KLRA) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/KLRA

Underlying data: Yahoo Finance; company filings with the SEC.